Novel arylimidazole derivatives, preparation and therapeutic uses thereof

Details for Australian Patent Application No. 2003273468 (hide)

Owner Societe de Conseils de Recherches et D'Applications Scientifiques (S.C.R.A.S.)

Inventors Liberatore, Anne-Marie; Chabrier De Lassauniere, Pierre-Etienne; Bigg, Dennis

Agent Watermark

Pub. Number AU-B-2003273468

PCT Number PCT/FR03/02336

PCT Pub. Number WO2004/011402

Priority 02/09416 25.07.02 FR

Filing date 24 July 2003

Wipo publication date 16 February 2004

Acceptance publication date 18 December 2008

International Classifications

C07D 233/64 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4178 (2006.01)

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/14 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/02 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 15/10 (2006.01) Drugs for genital or sexual disorders

A61P 15/12 (2006.01) Drugs for genital or sexual disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

Event Publications

5 February 2004 Complete Application Filed

  Priority application(s): 02/09416 25.07.02 FR

25 March 2004 Application Open to Public Inspection

  Published as AU-B-2003273468

18 December 2008 Application Accepted

  Published as AU-B-2003273468

12 March 2009 Alteration of Name

  The name of the applicant has been altered to IPSEN Pharma S.A.S

23 April 2009 Standard Patent Sealed

17 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003273469-NOVEL METHOD FOR ANALYZING NUCLEIC ACID ET USE THEREOF FOR EVALUATING THE DEGREE OF MRNA EDITING OF THE SEROTONIN 5-HTLESS THANSBGREATER THAN2CLESS THAN/SBGREATER THAN RECEPTOR

2003273467-METHOD OF PREPARING AN ESTER OF AN AROMATIC CARBOXYLIC ACID BEARING AT LEAST ONE PERFLUOROALKYL GROUP